Organized in coordination between the University of Geneva Faculty of Medicine  and the Geneva University Hospitals, Switzerland.

Preliminary program in pdf available here.

Monday, April 7th 2025.  

8:00       Registration

10.00     Welcome Note of the Organizers

10. 15      Welcome Note of the Dean, Medical Faculty, University of Geneva

Opening lectures (Keynote)

10.30      The current landscape of emerging viruses: WHO’s perspective

Speaker tbc

11.15      The current landscape of new vaccines and vaccine innovation

Speaker tbc

12.00 Lunch break

Session I: Arboviruses – in Europa and on a global scale

13.00 Clinical primer Imported West Nile Virus in an immunocompromised host

Pauline Vetter, University Hospitals of Geneva, Switzerland

13.10 Mosquito surveillance and vector competence in Switzerland

Eva Veronesi, SUPSI, Bellinzona, Switzerland

13.35 Autochthonous arbovirus outbreaks in France

Xavier de Lamballerie, CNR Arbovirus, Marseille, France

14.00 Vaccines against Arboviruses

Anna Durbin, John-Hopkins-University, USA

14.25 Oropouche virus – the next emerging arbovirus?

Speaker tbc

14.50 Coffee break

Session II: Enteroviruses

15.10     Clinical primer

Speaker tbc

15.20  Enteroviruses - harmless fellow passengers or next disease X?

 Heli Harvala, University of Turku, Finland

15.45     Enteroviruses evolution and diversity

Speaker tbc

16.10 Mini-Break

Session III: Hot topic

16.30       To be announced shortly before the meeting

Speaker tbc

16.55       Mini-Break

Session III: Prepardness in Switzerland

17.05 Prepardness in Switzerland

 Speaker tbc

Evening Lectures (Keynote)

17.45     Welcome Note of the Medical Director/CEO of the hospital

18.40   There will be no warning for the next pandemic

Justin Lessler, John Hopkins University, USA

Social Program

19.15       Apero

Tuesday , April 8th 2025. 

Session I: Influenza viruses

9.00         Clinical primer

Speaker tbc

9.15         How to select the next influenza vaccine

Kanta Subarrao, Laval University, Canada

9.40         What did we learn from COVID vaccine to inform design of better Influenza vaccines?

Robert Van der Most, VaxxCellence

10.05       Pepandemic vaccins

Speaker tbc

10.30       Coffee Break

Session II: Poxviruses

11.00     Clinical primer 

Stephano Musumeci, University Hospitals of Geneva, Switzerland

11.15       Mpox in DRC

Placide Mbala, National Institute of Biomedical Research, Democratic Republic of Congo

11.40      The UNITY trial

Alexandra Calmy, University Hospital of Geneva, Switzerland

12.05      Mpox vaccine update

Kari Johanson, The Public Health Agency, Sweden

12.30      Mpox is the return of Smallpox

Laurent Kaiser, University Hospital of Geneva, Switzerland

13.00       Lunch Break

Session III: Coronaviruses

14.00       Adaptive immune responses are larger and functionally preserved in a COVID-19 hypervaccinated individual

Kilian Schober, University of Erlangen, Germany

14.15       Viral evolution of SARS-CoV-2 and genomic surveillance

 Tulio Oliveira, Centre for Epidemic Response and Innovation, South Africa

14.40      MERS-vaccine

Marylyn Addo, UKE, Germany

15.05       Towards a pan-sarbecovirus vaccine to protect against SARS-CoV-2 variants and animal sarbecoviruses

Pamela Bjorkman, California Institute of Technology, USA,

15.30       Coffee Break

Session IV: Animal vaccination and the One Health Approach

16.00      Clinical primer

Speaker tbc

16.15       One Health: vaccination approaches in animals

 Joris Vandeputte

16.40     One Health influenza

Martin Beer, Friedrich-Loeffler-Institute, Germany

17.05     Work in greenland permafrost

 Marion Koopmans, Erasmus Medical Centre  

17.35      Prospects and approaches for hunting viral spillovers: Nipah virus in Bangladesh as a case study 

Emily Gurley, John Hopkins University

18.30       Mini Break

Evening Lecture (Keynote)

18.45       Emerging viruses & vaccination in times of humanitarian crisis

Jerome Singh, University of Toronto, Canada

Social Program

20.00     Conference dinner

Wednesday, April 9th 2025.

Session I: Marburg Virus Diseases

09.00       Clinical primer

Frédérique Jacquerioz, University Hospital of Geneva, Switzerland

09.15       Marburg outbreak Rwanda

Eric Seruyange 

09.40       Treatment of Marburg virus

Amanda Rojek 

10.05       Use of genomics during an outbreak

Speaker tbc

10.30       Vaccination against Marburg

Claude Mambo Muvunyi 

10.55      Coffee break

Session II: Towards eradication by vaccination

11.20       Measles eradication

Peter Strebel, World Health Organization, Switzerland

11.45       Poxvirus eradication

Rao, Agam K., Center for Disease Control and Prevention, USA

12.30       Closing Remarks & Farewell

 

           ***

 

logoHUG.png medecine70.gif